|
![]() |
|||
|
||||
OverviewPandemic influenza is a re-emerging pathogen with serious public health consequences. The A(H1N1) pandemic in 2009/10 and the continuing threat to humans from avian influenza A(H5N1) and other novel influenza viruses have both underlined the importance of preparedness at local, national and international levels. With a strong emphasis on practicality, this book offers comprehensive coverage of the science and operational application of influenza epidemiology, virology and immunology, vaccinology, pharmaceutical and public health measures, biomathematical modelling, policy issues and ethics involved in preparing for and responding to pandemic influenza. Each chapter raises key questions and answers them in clear and concise sections, detailing relevant modelling studies and further reading. Comprehensively updated to incorporate major lessons from the 2009/10 pandemic, this second edition includes new contributions on surveillance, International Health Regulations, clinical management and local health service responses, illustrated with vibrant international case studies. Written in an easily accessible style by global experts, this is an essential text for students of public health and those involved in local, national and international pandemic preparedness and response. Full Product DetailsAuthor: John Watson (Health Protection Agency, London) , Jonathan Van-Tam (Professor of Health Protection, City Hospital, Nottingham, UK) , Richard Pebody , Chloe Sellwood (NHS England and University of Nottingham, UK)Publisher: CABI Publishing Imprint: CABI Publishing Edition: 2nd edition Dimensions: Width: 18.90cm , Height: 2.20cm , Length: 24.60cm Weight: 0.950kg ISBN: 9781845938567ISBN 10: 1845938569 Pages: 264 Publication Date: 20 December 2012 Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contentsa: Contributorsb: Editor Biographiesc: Forewordd: Acknowledgementse: Glossary1: Epidemiology and clinical features of interpandemic influenza2: Influenza surveillance and pandemic requirements3: Basic influenza virology and immunology,br>Influenza in birds and mammals4: History and epidemiological features of pandemic influenza5: Epidemiology of pandemic influenza A(H1N1)pdm096: Clinical features and treatment of pandemic influenza A(H1N1)pdm097: Influenza transmission and infection control issues8: Pandemic preparedness9: Emergency preparedness and business continuity planning10: The role of exercises in pandemic preparedness11: Local health services responses to the 2009 pandemic12: Bio-mathematical modelling and pandemic preparedness13: Pharmaceutical Interventions14: Pandemic vaccines15: National and international public health measures16: Port Health and International Health Regulations17: Socio-economic impact18: Ethical issues related to pandemic preparedness and response19: Pandemic CommunicationCase Study 1: MexicoCase Study 2: ChileCase Study 3: New ZealandCase Study 4: The former Soviet UnionCase Study 5: AfricaCase Study 6: DenmarkCase Study 7: South East AsiaCase Study 8: North AmericaCase Study 9: Saudi Arabiaf: IndexReviewsAuthor InformationJonathan Van-Tam, MBE BMedSci (Hons) BMBS DM FFPH FRSPH, is Professor of Health Protection at the University of Nottingham. He graduated in medicine in 1987 and after several years of clinical work, completed academic training in epidemiology and public health, with a special interest in influenza that now spans almost 20 years. He brings a wealth of experience to this book including formative training in influenza under the mentorship of Professor Karl Nicholson, and private sector experience with two major pharmaceutical companies (both manufacturers of neuraminidase inhibitors) and a large European vaccines company. He returned to the public sector in 2007 and was Head of the Health Protection Agency, Pandemic Influenza Office during the most frenetic period of UK preparedness activity from 2004 to 2007. He has served as both Temporary Adviser and Short Term Consultant to the World Health Organization (WHO) regarding pandemic preparedness on numerous occasions, and has also undertaken related scientific work for the European Centre for Disease Prevention and Control (ECDC). He is a serving member of the UK national Scientific Pandemic Influenza Committee (SPI), its Clinical Countermeasures Sub-Group and a member of the newly formed UK Scientific Advisory Group for Emergencies (SAGE). Tab Content 6Author Website:Countries AvailableAll regions |